Zobrazeno 1 - 10
of 215
pro vyhledávání: '"William H. Daughaday"'
Autor:
Janet M. D. Plate, Michael Karl, Stephanie A. Gregory, Alessandra Vottero, Susan E. Taymans, George P. Chrousos, Constantine A. Stratakis, Homayoun Shahidi, Carlos Alberto Longui, William H. Daughaday
Publikováno v:
Biochemical and Biophysical Research Communications. 254:559-565
The human glucocorticoid receptor (GR) is expressed as two alternatively spliced isoforms, GRalpha and GRbeta. Whereas GRalpha is a hormone-activated transcription factor, GRbeta does not bind glucocorticoids (GCs), is transcriptionally inactive, and
Autor:
William H, Daughaday
Publikováno v:
Pediatric endocrinology reviews : PER. 10(3)
This vignette summarizes some of the scientific accomplishments of Dr. William H. Daughaday, a founder of modern research into the biological effects of growth hormone and the insulin-like growth factors, and formulator of the somatomedin hypothesis
Autor:
William H. Daughaday
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 89:3-5
The concentration of free IGF-I and -II in normal human serum is less than 0.5% of the total concentration of the IGF (1). Despite the fact that this component is critical in the feedback regulation of pituitary GH secretion and is important in the e
Autor:
Jack van Hoff, Patrick J. Buckley, William H. Daughaday, Elizabeth A. Korn, Thomas O. Carpenter
Publikováno v:
Medical and Pediatric Oncology. 24:392-396
A 5-year-old boy with an abdominal mass was found to have a primary renal tumor of poorly identifiable histology. Prior to resection of the tumor, the patient exhibited several episodes of biochemical hypoglycemia. The hypoglycemia did not recur afte
Publikováno v:
Endocrine. 3:425-428
The syndrome of non-islet cell tumor hypoglycemia (NICTH) is the result of hypersecretion of IGF-II by a tumor although serum IGF-II is seldom elevated. This is attributable to abnormalities of the IGF binding proteins (IGFBPs) present in NICTH which
Publikováno v:
Proceedings of the National Academy of Sciences. 90:5823-5827
The insulin-like growth factor II (IGF-II) gene is overexpressed in many mesenchymal tumors and can lead to non-islet-cell tumor hypoglycemia (NICTH). ProIGF-II consists of the 67 aa of IGF-II with a carboxyl 89-aa extension, the E domain. A derivati
Autor:
William H. Daughaday
Publikováno v:
Endocrinology and Metabolism Clinics of North America. 21:633-647
Autor:
Bakula Trivedi, William H. Daughaday
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 75:641-645
We have reported that normal human sera contain immunoactivity (IA) detected by a RIA directed against the first 21 amino acids of the E domain of proinsulin-like growth factor-II (pro-IGF-II). Marked elevations of E-21 IA were found in the serum of
Autor:
Robert C. Baxter, William H. Daughaday
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 73:696-702
In some subjects with hypoglycemia associated with tumors of mesenchymal origin, high insulin-like growth factor-II (IGF-II) levels have been described in serum and in the tumors. Tumor IGF-II of 10-15 kDa circulates in a 60-kDa complex, in contrast
Autor:
Thomas F. Deuel, William H. Daughaday
Publikováno v:
Endocrinology and Metabolism Clinics of North America. 20:539-563
An increasing number of polypeptide growth factors have been identified that regulate not only cell proliferation but also an extraordinary range of cell activities, including matrix protein deposition and resolution, the maintenance of cell viabilit